Skip to Content

Tebentafusp-tebn (Kimmtrak®) for Patients with Unresectable or Metastatic Uveal Melanoma

Download PQI pdf 0.3MB

Last Updated: December 12, 2024

By: Marlana Orloff, MD | Madeleine Naccarato, NP

About this PQI

The purpose of this PQI is to discuss clinical considerations surrounding the use of tebentafusp-tebn for patients with uveal melanoma and to review possible adverse events.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI